没事儿,产品卖遍全球,除了美国。而且,联邦在二年前就批了1.6B开发预购款。
KEY POINTS
- The U.S. government has awarded Novavax $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States.
- The company aims to deliver 100 million doses by January 2021.
- The award is the biggest yet from “Operation Warp Speed,” the White House program aimed at accelerating access to vaccines and treatments to fight the coronavirus that causes Covid-19.
